Greatly, encouraged with the wide acceptance and positive trend, it entered in other segments like Cardiovascular, Ant-malaria, Anti-diabetic, Anti-tuberculosis, Gynecological, Gastroenterological and Bulk drugs.
Today, Maty is manufacturing and marketing over 150 brands and generics in different strength. The market share of its formulations has grown remarkably because of the company’s strong and modern infrastructure, modern manufacturing facilities with WHO GMP compliance, innovative marketing strategies with a sound financial base and highly motivated man power with expertise, skills and dedication in their respective fields of operation. |
